Ujvira 100mg Trastuzumab Emtansine Injection

Ujvira 100mg Trastuzumab Emtansine Injection is a prescription targeted anti-cancer medication used in the treatment of HER2-positive breast cancer. It contains Trastuzumab Emtansine (T-DM1), an antibody-drug conjugate that combines the HER2-targeting action of trastuzumab with a chemotherapy agent, allowing the treatment to deliver cancer-fighting medication directly to HER2-positive cancer cells. By specifically targeting tumor cells, Ujvira 100mg Trastuzumab Emtansine Injection helps slow cancer growth while limiting damage to healthy tissues. Administered as an intravenous infusion under the supervision of an oncology specialist, it is commonly used in patients who have previously received anti-HER2 therapies. Regular monitoring of liver function, blood counts, and cardiac health is important during treatment to ensure safety and effectiveness. Patients should use Ujvira 100mg Injection only as prescribed by their healthcare provider.